Erin DeRuggiero

in 2018. She is focused on building accelerated growth focused companies that deliver a collaborative and loyal corporate culture. She’s spent her career developing new digital and data product solutions, paired with industry leading commercialization strategy. The AI fueled insights platform she pioneered provides omni channel personalization and next best action decision making to top 25 pharmaceutical companies in the US. She’s a fast-rising healthcare entrepreneur and executive, blazing a new path for data marketing, predictive analytics, machine learning and female-led startups.

Prior to the acquisition, Erin was the Founder and CEO of TI Health, bringing more than 25 years of digital advertising, data, and healthcare analytics platform experience to the organization. She has served on both public and private boards, received numerous industry accolades including recognition as one of MM&M’s “25 Women of Distinction” and PM360’s “Data Miner of the Year” in 2022 and Folio’s “Top Woman in Media” in 2021. Erin’s industry expertise has been featured as a guest contributor to Fierce Pharma, AdAge, Healthcare Brew as well as on stage as a keynote speaker at JP Morgan, panelist at Digital Pharma East and SXSWi.

Prior to TI Health, Erin co-founded SRAX and SRAXmd, successfully up-listing to NASDAQ two years post launch, a milestone for a healthcare tech startup taking a company public. Erin graduated from Macalester College in St Paul, MN and was accepted into Brown's Class of 2026 for a Masters in Public Health.